6c3fd2dd__Trials_Monthly___October_2013__Description
[NCI Designation] NCT01716715 [Disease Site] Ovarian, Fallopian Tube, Peritoneal Cancers [Description] 
A Randomized Phase I Study of NCI Supplied Cabozantinib (Nsc #761968 Ind #116059) versus Weekly Paclitaxel (Nsc #673089) in the Treatment Of Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Seattle Cancer Care Alliance | Clinical Trials Monthly - October 2013
Description